The data collected through the EUonQoL-Kit plays a pivotal role in enhancing cancer care across Europe by providing comprehensive insights into the quality of life (QoL) of individuals affected directly by cancer. This aggregated QoL data is intended for use by various stakeholders, including policymakers, healthcare providers, researchers, and patient advocacy groups, to inform decisions and strategies that improve patient outcomes and societal well-being.
National, regional, and local policymakers are primary users of the aggregated QoL data. By analyzing this data, they can make informed decisions to enhance healthcare systems and develop policies that directly improve patients' physical, emotional, and social well-being.
Patient advocacy organizations and non-governmental organizations can leverage the QoL data to advocate for Patient Needs, develop support programs, and raise awareness.
The research community can use the rich, standardized QoL data to advance cancer care knowledge, inform evidence-based practices, and facilitate international collaboration.
Healthcare professionals, including oncologists, general practitioners, nurses, and allied health workers, can utilize the aggregated QoL data to enhance patient care by tailoring treatment plans, improving clinical outcomes, and enhancing patient-centered care.